Literature DB >> 11704282

Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules.

J Sidney1, S Southwood, D L Mann, M A Fernandez-Vina, M J Newman, A Sette.   

Abstract

The A*0201, A *0202, A*0203, A*0206, and A*6802 binding capacity of single amino acid substitution analogs of known A2-supertype binding peptides and of large nonredundant peptide libraries was measured. The results were utilized to rigorously define the peptide binding specificities of these A2-supertype molecules. Although each molecule was noted to have unique preferences, large overlaps in specificity were found. The presence of L, I, V, M, A, T, and Q residues in position 2, and L, I, V, M, A, and T residues at the C-terminus of peptide ligands were tolerated by all molecules. Likewise, whereas examination of secondary influences on peptide binding revealed allele specific preferences, shared features could also be identified. These shared features were utilized to define an A2-supermotif and were noted to correlate with crossreactivity. Over 70% of the peptides that bound A *0201 with high affinity were found to bind at least two other A2-supertype molecules. Because the A2-supertype molecules studied herein cover the variants most common in different major ethnicities, these findings have important implications for epitope-based approaches to vaccination, immunotherapy, and the monitoring of immune responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704282     DOI: 10.1016/s0198-8859(01)00319-6

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  64 in total

1.  A comparative molecular similarity index analysis (CoMSIA) study identifies an HLA-A2 binding supermotif.

Authors:  Irini A Doytchinova; Darren R Flower
Journal:  J Comput Aided Mol Des       Date:  2002 Aug-Sep       Impact factor: 3.686

2.  Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?

Authors:  Thorsten U Vogel; Thomas C Friedrich; David H O'Connor; William Rehrauer; Elizabeth J Dodds; Heather Hickman; William Hildebrand; John Sidney; Alessandro Sette; Austin Hughes; Helen Horton; Kathy Vielhuber; Richard Rudersdorf; Ivna P De Souza; Matthew R Reynolds; Todd M Allen; Nancy Wilson; David I Watkins
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Functional analysis of frequently expressed Chinese rhesus macaque MHC class I molecules Mamu-A1*02601 and Mamu-B*08301 reveals HLA-A2 and HLA-A3 supertypic specificities.

Authors:  Scott Southwood; Christopher Solomon; Ilka Hoof; Richard Rudersdorf; John Sidney; Bjoern Peters; Angela Wahl; Oriana Hawkins; William Hildebrand; Bianca R Mothé; Alessandro Sette
Journal:  Immunogenetics       Date:  2011-01-28       Impact factor: 2.846

4.  Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201.

Authors:  Hua Cong; Ernest J Mui; William H Witola; John Sidney; Jeff Alexander; Alessandro Sette; Ajesh Maewal; Rima McLeod
Journal:  Vaccine       Date:  2010-11-21       Impact factor: 3.641

5.  Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with dual MHC class I and class II specificities: a new strategy for vaccine design.

Authors:  Gang Zeng; Yong Li; Mona El-Gamil; John Sidney; Alexandro Sette; Rong-fu Wang; Steven A Rosenberg; Paul F Robbins
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

Review 6.  Structural and functional distinctiveness of HLA-A2 allelic variants.

Authors:  Kenneth Yuanxiang Chen; Jingxian Liu; Ee Chee Ren
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

7.  Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans.

Authors:  Tze Guan Tan; Ernest Mui; Hua Cong; William H Witola; Alexandre Montpetit; Stephen P Muench; John Sidney; Jeff Alexander; Alessandro Sette; Michael E Grigg; Ajesh Maewal; Rima McLeod
Journal:  Vaccine       Date:  2010-03-26       Impact factor: 3.641

8.  HLA-A2 supertype-restricted cell-mediated immunity by peripheral blood mononuclear cells derived from Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls.

Authors:  Kirsten E Lyke; Robin B Burges; Yacouba Cissoko; Lansana Sangare; Abdoulaye Kone; Modibo Dao; Issa Diarra; Marcelo A Fernández-Vina; Christopher V Plowe; Ogobara K Doumbo; Marcelo B Sztein
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

9.  Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications.

Authors:  Huynh-Hoa Bui; John Sidney; Bjoern Peters; Muthuraman Sathiamurthy; Asabe Sinichi; Kelly-Anne Purton; Bianca R Mothé; Francis V Chisari; David I Watkins; Alessandro Sette
Journal:  Immunogenetics       Date:  2005-05-03       Impact factor: 2.846

10.  Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity.

Authors:  Alessandro Sette; John Sidney; Huynh-Hoa Bui; Marie-France del Guercio; Jeff Alexander; John Loffredo; David I Watkins; Bianca R Mothé
Journal:  Immunogenetics       Date:  2005-03-04       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.